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Abstract
Background—When making decisions about medication use in pregnancy, women consult 
many information sources, including the Internet. The aim of this study was to assess the content 
of publicly-accessible YouTube videos that discuss medication use in pregnancy.
Methods—Using 2,023 distinct combinations of search terms related to medications and 
pregnancy, we extracted metadata from YouTube videos using a YouTube video Application 
Programming Interface. Relevant videos were defined as those with a medication search term and 
a pregnancy-related search term in either the video title or description. We viewed relevant videos 
and abstracted content from each video into a database. We documented whether videos implied 
each medication to be ‘safe’ or ‘unsafe’ in pregnancy and compared that assessment with the 
medication’s Teratogen Information System (TERIS) rating.
Results—After viewing 651 videos, 314 videos with information about medication use in 
pregnancy were available for the final analyses. The majority of videos were from law firms 
(67%), television segments (10%), or physicians (8%). Selective serotonin reuptake inhibitors 
(SSRIs) were the most common medication class named (225 videos, 72%), and 88% percent of 
videos about SSRIs indicated they were ‘unsafe’ for use in pregnancy. However, the TERIS 
ratings for medication products in this class range from ‘unlikely’ to ‘minimal’ teratogenic risk.
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Conclusion—For the majority of medications, current YouTube video content does not 
adequately reflect what is known about the safety of their use in pregnancy and should be 
interpreted cautiously. However, YouTube could serve as a valuable platform for communicating 
evidence-based medication safety information.
Keywords
YouTube; Medications; Pregnancy; Social Media; Drug Safety
INTRODUCTION
Medication use in pregnancy has increased over the past 30 years with the majority of 
pregnant women (90%) in the United States reporting use of at least one medication during 
pregnancy.1 However, the safety of most commonly used medications in pregnancy is still 
unknown due to insufficient data.2 In addition, accurate sources of information on the safety 
of medications in pregnancy can be challenging to find for both clinicians and pregnant 
women, which can impact the ability to make informed treatment decisions.
YouTube has become one of the largest social media platforms with an estimated one billion 
unique viewers per month and over six billion hours of video watched monthly.3 Given the 
popularity of YouTube, several studies have assessed the quality of information in YouTube 
videos related to health conditions and behaviors, including immunizations,4 prostate 
cancer,5 the 2009 H1N1 influenza pandemic,6 infantile spasms,7 kidney stone disease,8 
cardiopulmonary resuscitation,9 pediatric tumors,10 inflammatory bowel disease,11 burn first 
aid,12 epilepsy,13 and cardiac auscultation.14
A 2010 survey of women from 24 countries reported that over 80% of pregnant women used 
the Internet to inform decision-making in pregnancy.15 With potentially many pregnant 
women searching the Internet for pregnancy information, it is important to evaluate the 
content of YouTube videos as sources of health information. The objective of our study was 
to assess information from systematically selected YouTube videos related to medication 
safety in pregnancy. We described video characteristics such as source and popularity, and 
assessed the accuracy of video content with respect to medication safety in pregnancy.
MATERIALS AND METHODS
Video Search Terms
To identify YouTube videos with content relevant to medication use in pregnancy, we 
assembled a list of the most common medication components taken in pregnancy from 
publications of self-reported medication use in the National Birth Defects Prevention Study 
and Slone Epidemiology Center Birth Defects Study2 and the National Health and Nutrition 
Examination Survey (NHANES).16 Based on the most frequently reported medication 
components, we compiled a list of 284 generic and brand name products (Supplemental 
eTable 1). We then added five general medication search terms (i.e. “SSRI”, “inhaler”, 
“bronchodilator”, “antibiotic”, and “antidepressant”) to mimic common terms a woman 
might use to search for video content. Each of these 289 medication search terms was then 
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paired with seven pregnancy-related terms (“pregnant”, “pregnancy”, “defect”, “congenital 
anomaly”, “congenital anomalies”, “birth defect”, and “birth anomalies”), generating a total 
of 2,023 distinct combinations of search terms.
Selection of Videos Using the Data Feed from YouTube’s Application Programming 
Interface (API)
Employing the list of search terms, we used a YouTube Application Programming Interface 
(API) video feed that searches video metadata to identify potential YouTube videos with 
medication and pregnancy-related content.17 YouTube API video feed data elements 
include, but are not limited to: video uniform resource locator (URL), author, title, 
description, author-selected category (e.g., news, education, how-to, people, entertainment, 
tech), dates of publication and updates, duration, number of views, number of comments, 
and ratings. The data extraction from the YouTube API video feed was performed on June 9, 
2014. To limit the sample of videos for viewing to those that would presumably be most 
relevant, we restricted the selection to those results with both a medication and pregnancy-
related search term in the title or description fields (n=651). All videos that met this criterion 
were imported into a Microsoft (MS) Access database. Additional information on our 
method for data extraction is available in the online supplemental material.
Abstraction of Information from Reviewed Videos
Following the initial data extraction, three members of the research team (CL, VJG, APG) 
watched the videos. One reviewer watched 466 videos (72%), one watched 156 videos 
(24%) and one watched 29 videos (4%). Team members abstracted the following 
information from each video into the MS Access database: presenter (gender, estimated 
age), source of the video (“advertisement”, “government [Food and Drug Administration: 
FDA]”, “government [other]”, “legal [law firm]”, “not for profit organization”, “patient/
family”, “physician”, “public health organization”, “TV clip”, or “university”), number of 
views, number of “thumbs up” or “thumbs down”, medications mentioned in the video, 
medication-associated adverse outcomes mentioned in the video, any FDA pregnancy 
category mentioned, and the safety of the medication(s) implied in the video. Regarding this 
last data element, if the video discussed any adverse effect on the mother or fetus associated 
with a particular medication, the rater assessed the video as implying that medication to be 
“unsafe”.
We attempted to categorize video sources as specifically as possible; hence, there was an 
inherent operational hierarchy to the categories. For example, “legal [law firm]” videos were 
classified as such if they were produced by a law firm with the intent of soliciting clients for 
a lawsuit, irrespective of where they might have been originally broadcast. Similarly, if a 
physician from a teaching hospital was speaking in an educational video aimed at patients, it 
was classified as “physician”, “university”. The more general terms of “TV clip” and 
“advertisement” were assigned to videos that did not clearly fit into one of the more source-
specific categories. Videos categorized as “TV clip” tended to be excerpts from news 
programs or interviews originally aired on television.
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If a video discussed more than one medication, the rater assessed the implied safety of each 
medication mentioned. If the reviewer felt that the video was not related to medication use 
in pregnancy, the reviewer could indicate that the video should be excluded and provide a 
reason for the exclusion. To check the accuracy of this abstraction process, 10% of the 
videos (n=67) were randomly selected and split between two additional members of the 
research team (ECA, SMG) to review. Of these videos, information from four videos (6%) 
was added or edited in the MS Access database.
For all medication products abstracted, we compared the safety of a medication’s use in 
pregnancy suggested in the YouTube video with the magnitude of risk rating listed in the 
Teratogen Information System (TERIS). TERIS is a subscription database that rates both the 
teratogenic risk of specific medication exposures in pregnancy and the quality of the data on 
risk of use in pregnancy.18
Statistical Analyses
Descriptive statistics (percentages, mean, minimum and maximum) were used to 
characterize the information abstracted from the videos. No inferential statistics were 
performed. We calculated the total days of potential viewing since the video was uploaded 
by subtracting the video publication date from the date of the video data extraction. We 
calculated measures of popularity, such as the “mean number of views per month”, by 
dividing the total number of views since uploading by the total days since uploading, and 
multiplying by 30. Similarly, for “thumbs-up” ratings, we divided the total “thumbs-up” 
since the video was uploaded by the total number of views since uploading, and multiplied 
by 1000 (e.g., mean “thumbs-up” per 1000 views).
All video feed extraction processes and statistical analyses were performed using SAS 9.4 
(SAS Institute, Cary, NC). The PROC HTTP procedure was used to perform the API video 
feed extraction, and the XML file was then parsed into a data structure using a map 
generated in the SAS XML Mapper 9.4.
RESULTS
YouTube API Video Feed
Our 2,023 search terms captured 41,438 distinct videos (Figure 1) from an initial 97,480 
videos from the multiple video feeds performed (e.g. there were duplicated videos captured 
by different search terms across the multiple video feeds). We excluded 40,787 videos in 
which the medication product and pregnancy-related search terms were not in the title or 
description of the video, leaving 651 videos with at least one medication product search term 
and at least one pregnancy-related search term in the title or description.
Characteristics of the Reviewed Videos
Of the 651 reviewed videos, 337 were excluded after viewing. Among the excluded videos, 
244 were excluded because the reviewer deemed the content of the video to be unrelated to 
medication use in pregnancy. The most common medication product search term among 
these 244 excluded videos was “clomid”, a treatment for infertility. Associated excluded 
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videos tended to chronicle women’s attempts to become pregnant. An additional 70 videos 
were excluded because the video was an exact duplicate of another video included in the 
analysis. Because the title and/or descriptions were different, however, the duplication was 
not detected during data cleaning. Twenty-three additional videos were excluded for other 
reasons (Figure 1). This left 314 videos in the final analyses.
Of the 314 videos we analyzed, the most common medication product search terms (in 
combination with a pregnancy search term) in the title or description were “antidepressant”, 
“SSRI”, “Zoloft”, and “Paxil” (Figure 2). The majority of videos were from a “legal” (67%), 
“TV clip” (9.9%) or “physician” (8.0%) source (Table 1). The 210 videos of “legal” origin 
were uploaded by 110 distinct authors (range: 1–16 videos per author). The “physician” 
category had the highest number of views per 30 days (332 views), followed by “not for 
profit organizations” (114 views). Videos from “not for profit organizations” had the highest 
mean number of thumbs-up (5.3 thumbs-up per 1000 views). Videos of “legal” origin were, 
on average, the shortest in duration (mean=1.4 minutes), and videos from “university” and 
“not for profit organizations” were the longest in duration (both ~13.7 minutes).
Medications Mentioned in the Videos
On average, three medications were mentioned per video (range: 1–15). Antidepressants 
were discussed in the majority of videos (249, 79%), of which 82% were of “legal” origin 
(Table 2). Selective serotonin reuptake inhibitors (SSRIs) were the most common 
medication class (225 videos) mentioned in the YouTube videos, and sertraline and 
paroxetine were the most commonly mentioned SSRIs, reported in 135 and 118 videos, 
respectively (Table 3). Serotonin-norepinephrine reuptake inhibitors (SNRIs) were the 
second most common medication class (41 videos), and venlafaxine was the most 
commonly mentioned drug in that class (37 videos). Other types of antidepressants, 
particularly bupropion, were also mentioned in 32 videos. There was low concordance 
between the safety suggested in YouTube videos and medication ratings in TERIS. Eighty-
eight percent of videos discussing SSRIs, SNRIs, or other antidepressants deemed them to 
be ‘unsafe’ for use in pregnancy (Table 3). The majority of these videos were from “legal” 
videos. However, TERIS ratings for specific SSRIs and other antidepressants ranged from 
‘unlikely’ to ‘minimal’ teratogenic risk and were ‘undetermined’ for many SNRIs.
Other medication types were less commonly mentioned in YouTube videos. After 
antidepressants, the next most common medication types mentioned included analgesics and 
antipyretics (26 videos, 8%), most of which were of “physician” or “TV clip” origin (46% 
and 27%, respectively), and hormones and synthetic substances (24 videos, 8%), most 
(42%) of which were from a “patient/family” source (Table 2). The majority of videos about 
analgesics and antipyretics focused specifically on acetaminophen (17 videos), with 29% of 
videos reporting it to be ‘unsafe’ during pregnancy despite the medication having a TERIS 
rating of ‘minimal’ teratogenic risk (Table 3). The majority of videos about hormones and 
synthetic substitutes focused specifically on antidiabetic medications (15 videos); the safety 
implied in the YouTube videos mostly agreed with the rating in TERIS for this medication 
type. Anticonvulsant, gastrointestinal, and antibacterial medication types were each 
mentioned in less than 25 videos (Table 2, Table 3). The timing of medication exposure in 
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pregnancy or the critical period of risk was not discussed in the majority of videos (233, 
74%) and only 13 videos (4%) mentioned FDA pregnancy categories (data not shown).
Adverse Pregnancy Outcomes Mentioned in the Videos
The adverse outcomes reported in the reviewed videos consisted mainly of specific birth 
defects (175 videos, 56%), followed by persistent pulmonary hypertension of the newborn 
(83 videos, 26%), non-specific birth defects (56 videos, 18%), and behavioral or 
developmental disabilities (35 videos, 11%) (Table 4). Congenital heart defects were the 
most common birth defects mentioned (160 videos, 51%), followed by craniofacial defects 
(100 videos, 32%), and neural tube defects (67 videos, 21%) (Table 4). When looking at 
reported adverse outcomes by medication class, heart defects and craniofacial defects were 
most often reported to be associated with antidepressants; most of the videos reporting these 
associations were of ”legal” origin (Table 5).
DISCUSSION
In this study, we reviewed over 600 YouTube videos and abstracted information from 314 
videos that provided information on the use of medications in pregnancy. Over two-thirds of 
reviewed videos were from law firms, and less than 10% of videos each were from other 
sources such as TV clips, physicians, universities, or government agencies. Antidepressants 
were the predominant medication type mentioned. Birth defects and heart defects, in 
particular, were the most common adverse pregnancy outcomes discussed. A comparison 
between a medication’s safety in pregnancy suggested in the YouTube video with the 
magnitude of risk rating listed in TERIS suggested that, for selected medications, such as 
SSRIs, the YouTube video content that we reviewed does not adequately reflect what is 
known about the medication’s teratogenic risk. People seeking information about the safety 
of medications in pregnancy from YouTube videos should be mindful of the information 
source when drawing conclusions about the teratogenic risk of specific medication products 
and consider the video content with caution. Our use of search terms such as “defect”, 
“congenital anomaly”, “congenital anomalies”, “birth defect”, and “birth anomalies” seemed 
to identify videos more likely to present medications as “unsafe” than “safe”.
In general, our findings are consistent with previous research that has found that the 
information related to the safety of medications in pregnancy on many websites is 
inconsistent and inadequate. For example, a 2013 study assessed information about the 
safety of medications in pregnancy and reported on content from 25 different websites and 
245 medications listed as “safe for use during pregnancy”. Researchers found that about 
40% of websites lacked sufficient data to support safety claims.19 A recent multinational 
study used an anonymous Internet-based questionnaire to assess the extent to which 
pregnant women use multiple information sources and the consequences of conflicting 
information. Results showed that almost all of the women surveyed used multiple 
information sources when seeking information on medication safety in pregnancy. About 
20% of the women surveyed reported that conflicting information led them to decide not to 
use a particular medication.20 A 2014 French study investigated the quality and reliability of 
information on medications in pregnancy in conversations in online forums. Researchers 
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reported that nearly 20% of the advice given in these online conversations lacked sufficient 
evidence to support their conclusions.21 For pregnant women this inconsistent information 
can lead to frustration and anxiety and may lead women to decide not to use a particular 
medication during pregnancy, even if the benefits of use outweigh the risks associated with 
medication exposure.
A strength of our study is the large set of empirically derived medication and pregnancy-
related terms we utilized to search YouTube metadata. It would not have been feasible to 
conduct a manual search of the same magnitude within YouTube. Furthermore, we were 
able to identify and review over 600 videos, more than the number of videos reviewed in 
other studies investigating health-related information available via YouTube.
Our study is subject to several limitations. First, we searched for videos within the YouTube 
API and although this was an efficient method that allowed for automated data capture, it 
did not replicate the process an individual would go through when conducting a manual 
search within YouTube. Specifically, we were not able to consider the order in which videos 
from a manual search might appear, which could be an important factor for users searching 
YouTube and could influence the likelihood that an individual would ever see a video. 
Nonetheless, by first extracting data from the YouTube API, we were able to cast a broad 
net and capture all videos regardless of the order in which a video would appear on a results 
page during a manual search.
Second, we excluded from consideration videos that did not have at least one pregnancy-
related and medication search term in either the title or description; this decision excluded 
over 40,000 videos from consideration. It is possible that some potentially relevant videos 
were not considered for review because of this exclusion rule.
Third, for some videos, it was challenging to discretely categorize the video source into a 
single category. The decision to categorize a video’s source when it was unclear or when it 
could fall into more than one category (e.g. distinction between “not for profit” and 
“university”) was made by the reviewer, which may have introduced a degree of information 
bias if reviewers were not consistent in their decision-making. For most videos, however, 
the origin was obvious.
Fourth, our assessment of whether the video noted the medication to be “safe” or “unsafe” 
was somewhat subjective and relied on the reviewer’s interpretation of the information 
presented in the video. However, based on the pre-established protocol for data abstraction, 
if the video discussed any adverse effect on the mother or fetus, raters uniformly assessed 
the video as noting that medication to be “unsafe”. There was insufficient information to 
have a more nuanced assessment of the video’s safety assessment. In addition, the terms of 
our search were selected to identify videos that discussed teratogenic effects of medication 
use in pregnancy. By including the pregnancy related search terms of “defect”, “congenital 
anomaly”, “congenital anomalies”, “birth defect”, and “birth anomalies”, we were, by 
design, seeking to identify videos that discussed these effects. It is important to note that 
broader search terms such as “preterm”, “low birth weight”, “complications”, “stillbirth” 
and “miscarriage” were not included. Therefore, we acknowledge that not all videos 
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discussing these broader adverse outcomes associated with medication use in pregnancy 
were captured in our analyses. Hence our results may be an underestimation of the incorrect 
information portrayed in YouTube videos.
Fifth, when videos discussed broad medication classes rather than a specific medication 
product, we could not compare the video’s safety assessment to a corresponding TERIS 
rating.
Lastly, grouping reported adverse outcomes was challenging, especially when videos were 
vague in the outcomes mentioned or reported multiple outcomes. Several videos needed to 
be re-reviewed during data analysis to clarify some of the health effects abstracted (e.g. 
when “jittery” was noted as an effect of a medication used in pregnancy, the video needed to 
be re-reviewed to determine whether that effect referred to the mother or the baby).
CONCLUSION
To our knowledge, this is the first assessment of the content of YouTube videos about 
medication use in pregnancy. For selected medications, such as SSRIs, the YouTube video 
content that we reviewed does not adequately reflect what is known about the safety of their 
use in pregnancy and video content should be interpreted with caution. Given the high 
utilization of the Internet for health information, YouTube could serve as a valuable 
platform for communicating evidence-based medication safety information in pregnancy. 
Credible sources, such as FDA, physicians, and CDC, should consider using YouTube as a 
platform for disseminating factual, reliable content on medication safety. Information 
communicated in YouTube videos can encourage women to discuss their treatment 
questions with their healthcare providers and can provide women with information to inform 
these conversations.
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• YouTube video content can be searched systematically to extract videos related 
to safety of medication use in pregnancy.
• The majority of YouTube videos reviewed were related to litigation.
• Antidepressants were the most commonly discussed medications in YouTube 
videos reviewed.
• For the majority of medications, current YouTube video content does not 
adequately reflect what is known about the safety of their use in pregnancy.
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Schematic overview of the video selection process.
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Distribution of medication search terms appearing in the title or description of included 
videos (n=314). Note: Videos can be double-counted when multiple medications appear in 
the title or description.
Notes: SSRI = selective serotonin reuptake inhibitor
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Table 4
Number of YouTube videos reviewed (n=314) about medication use in pregnancy, by adverse outcome 
mentioned1
Adverse Outcome n2 %
Specific birth defects 175 55.7
  Heart defects 160 51.0
  Craniofacial defects 100 32.0
  Neural tube defects 67 21.3
  Abdominal defects 53 17.0
  Club feet 53 17.0
  Lung defects 51 16.2
  Limb defects 27 8.6
  Anal defects 12 3.8
  Muscular/skeletal defects 6 1.9
  Brain defects 6 1.9
  Genital defects 4 1.3
  Chromosomal abnormalities 2 0.6
Nonspecific birth defects3 56 17.8
PPHN 83 26.4
Behavioral/developmental disabilities4 35 11.2
Non-birth defect complications in the infant 21 6.7
Neonatal abstinence syndrome 12 3.8
Death 5 1.6
Outcomes related to the mother 28 8.9
Birth related complications5 19 6.1
None 7 2.2
Missing 53 16.9
Notes: PPHN=Persistent pulmonary hypertension of the newborn
1
All groups are indicators (i.e., videos could report more than one effect for every medication discussed and are therefore counted in each group 
indicated); exception to this is nonspecific birth defects when a birth defect by location was also given (see note below).
2
Some videos discussed more than one effect (i.e., they might be represent more than once in this column), therefore, the sum of videos within 
each effect type will not equal the number of videos for each effect type.
3
Only includes videos in which no specific birth defects were mentioned.
4
Includes autism, developmental disabilities not otherwise specified, and behavioral problems not otherwise specified.
5
Includes preterm birth, miscarriage, low birth weight, and general birth complications.
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